| Bortezomib |
20150191 |
Vortemyel, Powder for solution for injection, 3.5, mg, Pack: 1 |
Alvogen IPCo S.àr.l, Люксембург |
Synthon Hispania SL, C/ Castelló № 1, Pol. Las Salinas, Sant Boi de Llobregat, 08830, Barcelona, Испания; Synthon s.r.o., Brnenska 32/c.p.597, Blansko, 678 01, Чехия |
1385.04 |
277.01 |
1662.05 |
4% |
10 |
1395.04 |
279.01 |
1674.05 |
16% |
25 |
1420.04 |
284.01 |
1704.05 |
|
НСР-6576/29.06.2015. |
29.06.2015 |
29.06.2015 |
Неактивен |
4014 |
| Sofosbuvir/velpatasvir/voxilaprevir |
EU/1/17/1223/001 |
Vosevi, Film coated tablet, 400 mg /100 mg /100 mg, mg, Pack: 28 |
Gilead Sciences Ireland UC, Ирландия |
Gilead Sciences Ireland UC, Ирландия |
23469.96 |
4693.99 |
28163.95 |
4% |
10 |
23479.96 |
4695.99 |
28175.95 |
16% |
25 |
23504.96 |
4700.99 |
28205.95 |
|
НСР-19790/10.09.2019 |
25.09.2019 |
02.10.2019 |
Активен |
16695 |
| Sofosbuvir/velpatasvir/voxilaprevir |
EU/1/17/1223/001 |
Vosevi, Film coated tablet, 400 mg /100 mg /100 mg, mg, Pack: 28 |
Gilead Sciences Ireland UC, Ирландия |
Gilead Sciences Ireland UC, Ирландия |
23469.96 |
4693.99 |
28163.95 |
4% |
10 |
23479.96 |
4695.99 |
28175.95 |
16% |
25 |
23504.96 |
4700.99 |
28205.95 |
|
НСР-19790/10.09.2019 |
25.09.2019 |
02.10.2019 |
Неактивен |
16695 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp. z o.o., Pieńków 149, 05-152 Czosnów, Полша |
5.34 |
1.07 |
6.41 |
7% |
0.37 |
5.71 |
1.14 |
6.85 |
20% |
1.07 |
6.78 |
1.36 |
8.14 |
|
НСР-7526/19.11.2015.; НСР-12083/21.03.2017 |
05.12.2015 |
02.05.2017 |
Заличен |
3090 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp. z o.o., Pieńków 149, 05-152 Czosnów, Полша |
5.34 |
1.07 |
6.41 |
7% |
0.37 |
5.71 |
1.14 |
6.85 |
20% |
1.07 |
6.78 |
1.36 |
8.14 |
|
НСР-7526/19.11.2015. |
05.12.2015 |
05.12.2015 |
Неактивен |
3090 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp. z o.o., Pieńków 149, 05-152 Czosnów, Полша |
6.67 |
1.33 |
8 |
7% |
0.47 |
7.14 |
1.43 |
8.57 |
20% |
1.33 |
8.47 |
1.69 |
10.16 |
|
НСР-4250/30.07.2014 |
26.08.2014 |
26.08.2014 |
Неактивен |
3090 |
| Rosuvastatin |
II-10742/ 13.09.2010 |
Vosustat, Film coated tablet, 20, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Pharma Swiss Ceska republiкa s.r.o. |
15.84 |
3.17 |
19.01 |
6% |
0.95 |
16.79 |
3.36 |
20.15 |
18% |
2.85 |
19.64 |
3.93 |
23.57 |
Цената се заличава с решение НСР-1995/06.12.2013 |
НСР-1508/25.10.2013 |
14.11.2013 |
14.11.2013 |
Заличен |
2220 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp. z o.o., Pieńków 149, 05-152 Czosnów, Полша |
9.37 |
1.87 |
11.24 |
7% |
0.66 |
10.03 |
2.01 |
12.04 |
20% |
1.87 |
11.9 |
2.38 |
14.28 |
корекц. НСР-4121/10.07.2014 |
НСР-1508/25.10.2013 |
14.11.2013 |
14.11.2013 |
Неактивен |
3090 |
| Rosuvastatin |
II-10742/ 13.09.2010 |
Vosustat, Film coated tablet, 20, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
25.07 |
5.01 |
30.08 |
6% |
1.5 |
26.57 |
5.31 |
31.88 |
18% |
4.51 |
31.08 |
6.22 |
37.3 |
промяна на обстоятелства решение КЦPP-2709/20.03.2013 |
КЦРР-688/30.05.2012 |
18.06.2012 |
18.06.2012 |
Неактивен |
2220 |
| Rosuvastatin |
II-10741/ 13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
13.08 |
2.62 |
15.7 |
6% |
0.78 |
13.86 |
2.77 |
16.63 |
18% |
2.35 |
16.21 |
3.24 |
19.45 |
промяна на обстоятелства решение КЦPP-2709/20.03.2013 |
КЦРР-688/30.05.2012 |
18.06.2012 |
18.06.2012 |
Неактивен |
3090 |
| Rosuvastatin |
№ ІІ - 10743/13.09.2010 |
Vosustat, Film coated tablet, 40, mg, Pack: 28 |
Pharma Swiss Ceska Republiкa s.r.o., Чешка република |
Adamed Sp,z.o.o Полша |
52.81 |
10.56 |
63.37 |
4% |
2.11 |
54.92 |
10.98 |
65.9 |
16% |
8.45 |
63.37 |
12.67 |
76.04 |
промяна на обстоятелства решение КЦPP-2709/20.03.2013; Цената се заличава с решение НСР-1995/06.12.2013 |
КЦ-2020/24.02.2011 |
11.03.2011 |
11.03.2011 |
Заличен |
1029 |
| Rosuvastatin |
II-10742/13.09.2010 |
Vosustat, Film coated tablet, 20, mg, Pack: 28 |
Galex d.d., Словения |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
33.25 |
6.65 |
39.9 |
6% |
2 |
35.25 |
7.05 |
42.3 |
18% |
5.99 |
41.24 |
8.25 |
49.49 |
|
КЦ-2006/15.02.2011 |
02.03.2011 |
02.03.2011 |
Неактивен |
2220 |
| Rosuvastatin |
II-10741/13.09.2010 |
Vosustat, Film coated tablet, 10, mg, Pack: 28 |
Galex d.d., Словения |
Adamed Sp.z.o.o.,Pienkow 149, 05-152 Czosnow, Полша |
18.87 |
3.77 |
22.64 |
8% |
1.51 |
20.38 |
4.08 |
24.46 |
20% |
3.77 |
24.15 |
4.83 |
28.98 |
|
КЦ-2006/15.02.2011 |
02.03.2011 |
02.03.2011 |
Неактивен |
3090 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Novartis Europharm Limited, Ирландия |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom; Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
4502.14 |
900.43 |
5402.57 |
4% |
10 |
4512.14 |
902.43 |
5414.57 |
16% |
25 |
4537.14 |
907.43 |
5444.57 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-76/06.03.2015; Промяна в обстоятелствата НСР-6988/24.08.2015; НСР-16363/02.08.2018 |
НСР-5200/04.12.2014; НСР-9614/23.06.2016 |
08.07.2016 |
02.09.2018 |
Активен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Novartis Europharm Limited, Ирландия |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom; Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
4502.14 |
900.43 |
5402.57 |
4% |
10 |
4512.14 |
902.43 |
5414.57 |
16% |
25 |
4537.14 |
907.43 |
5444.57 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-76/06.03.2015; Промяна в обстоятелствата НСР-6988/24.08.2015; НСР-16363/02.08.2018 |
НСР-5200/04.12.2014; НСР-9614/23.06.2016 |
08.07.2016 |
02.09.2018 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom; Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
4502.14 |
900.43 |
5402.57 |
4% |
10 |
4512.14 |
902.43 |
5414.57 |
16% |
25 |
4537.14 |
907.43 |
5444.57 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-76/06.03.2015; промяна в обстоятелствата НСР-6988/24.08.2015 |
НСР-5200/04.12.2014; НСР-9614/23.06.2016 |
08.07.2016 |
02.08.2016 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Novartis Europharm Limited, Обединено Кралство |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom; Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
4531.97 |
906.39 |
5438.36 |
4% |
10 |
4541.97 |
908.39 |
5450.36 |
16% |
25 |
4566.97 |
913.39 |
5480.36 |
Отхвърлена жалба от Комисия по прозрачност с решение КП-76/06.03.2015; промяна в обстоятелствата НСР-6988/24.08.2015 |
НСР-5200/04.12.2014 |
02.04.2015 |
02.04.2015 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
5045.18 |
1009.04 |
6054.22 |
4% |
10 |
5055.18 |
1011.04 |
6066.22 |
16% |
25 |
5080.18 |
1016.04 |
6096.22 |
|
НСР-3113/26.03.2014 |
10.04.2014 |
10.04.2014 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) Priory Street Ware Herfordshire SG12 ODJ United kingdom Glaxo Wellcome SA. Avda. Extremadura, 309400 Aranda De Duero, Burgos Spain |
5055.39 |
1011.08 |
6066.47 |
4% |
10 |
5065.39 |
1013.08 |
6078.47 |
16% |
25 |
5090.39 |
1018.08 |
6108.47 |
|
КЦРР-2108/28.01.2013 г |
28.01.2013 |
28.01.2013 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Operations UK Ltd United Kingdon Glaxo Wellcome, S.A. Spain |
5066.38 |
1013.28 |
6079.66 |
4% |
10 |
5076.38 |
1015.28 |
6091.66 |
16% |
25 |
5101.38 |
1020.28 |
6121.66 |
|
КЦРР-1824/12.12.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 400, mg, Pack: 60 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Operations UK Ltd United Kingdon Glaxo Wellcome, S.A. Spain |
5319.6 |
1063.92 |
6383.52 |
4% |
10 |
5329.6 |
1065.92 |
6395.52 |
16% |
25 |
5354.6 |
1070.92 |
6425.52 |
|
КЦ-1737/10.09.2010 |
01.10.2010 |
01.10.2010 |
Неактивен |
3669 |
| Pazopanib |
EU/1/10/628/001 |
VOTRIENT, Film coated tablet, 200, mg, Pack: 30 |
Novartis Europharm Limited, Ирландия |
Glaxo Operations UK Ltd United Kingdon Glaxo Wellcome, S.A. Spain |
1263.88 |
252.78 |
1516.66 |
4% |
10 |
1273.88 |
254.78 |
1528.66 |
16% |
25 |
1298.88 |
259.78 |
1558.66 |
промяна в обстоятелствата НСР-6989/24.08.2015; НСР-16361/02.08.2018 |
НСР-3114/26.03.2014 |
10.04.2014 |
02.09.2018 |
Активен |
2624 |
| Pazopanib |
EU/1/10/628/001 |
VOTRIENT, Film coated tablet, 200, mg, Pack: 30 |
Novartis Europharm Limited, Ирландия |
Glaxo Operations UK Ltd United Kingdon Glaxo Wellcome, S.A. Spain |
1263.88 |
252.78 |
1516.66 |
4% |
10 |
1273.88 |
254.78 |
1528.66 |
16% |
25 |
1298.88 |
259.78 |
1558.66 |
промяна в обстоятелствата НСР-6989/24.08.2015; НСР-16361/02.08.2018 |
НСР-3114/26.03.2014 |
10.04.2014 |
02.09.2018 |
Неактивен |
2624 |
| Pazopanib |
EU/1/10/628/001 |
VOTRIENT, Film coated tablet, 200, mg, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Glaxo Operations UK Ltd United Kingdon Glaxo Wellcome, S.A. Spain |
1263.88 |
252.78 |
1516.66 |
4% |
10 |
1273.88 |
254.78 |
1528.66 |
16% |
25 |
1298.88 |
259.78 |
1558.66 |
промяна в обстоятелствата НСР-6989/24.08.2015 |
НСР-3114/26.03.2014 |
10.04.2014 |
10.04.2014 |
Неактивен |
2624 |
| Pazopanib |
EU/1/10/628/004 |
VOTRIENT, Film coated tablet, 200, mg, Pack: 30 |
Glaxo Group Ltd., Обединено Кралство |
Glaxo Operations UK Ltd United Kingdon Glaxo Wellcome, S.A. Spain |
1310.78 |
262.16 |
157294 |
4% |
10 |
1320.78 |
264.16 |
1584.94 |
16% |
25 |
1345.78 |
269.16 |
1614.94 |
|
HCР-282/28.06.2013. |
17.07.2013 |
17.07.2013 |
Неактивен |
2624 |